Zoledronic acid for the prevention of bone metastases in patients with breast cancer

被引：0
作者：
Coleman, R. [1 ]
Gralow, J. [2 ]
Bell, R. [3 ]
Lipton, A. [4 ]
机构：
[1] Acad Unit Clin Oncol, Sheffield, S Yorkshire, England
[2] Univ Washington, Sch Med Seattle Canc Care Alliance, Seattle, WA USA
[3] Andrew Love Canc Ctr, Geelong, Vic, Australia
[4] Milton S Hershey Med Ctr, Hershey, PA USA
来源：
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(04)90666-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
63
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
[11]   Zoledronic acid for the treatment of bone Metastases in patients with breast cancer and other solid tumors [J].
Lacerna, L ;
Hohneker, J .
SEMINARS IN ONCOLOGY, 2003, 30 (05) :150-160
[12]   Impairment of renal function in the breast cancer patients with bone metastases treated with zoledronic acid [J].
Ito, Tokiko ;
Ono, Mayu ;
Oba, Takaaki ;
Hanamura, Toru ;
Kanai, Toshiharu ;
Maeno, Kazuma ;
Hiraguri, Manabu ;
Shingu, Kiyoshi ;
Kaneko, Gengo ;
Ito, Ken-ichi .
ANNALS OF ONCOLOGY, 2015, 26 :103-103
[13]   IMPAIRMENT OF RENAL FUNCTION IN THE BREAST CANCER PATIENTS WITH BONE METASTASES TREATED WITH ZOLEDRONIC ACID [J].
Ito, T. ;
Shingu, K. ;
Kaneko, G. ;
Ito, K. -I. .
ANNALS OF ONCOLOGY, 2013, 24
[14]   A Comparison of Denosumab Versus Zoledronic Acid for the Prevention of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases [J].
Stopeck, A. ;
de Boer, R. ;
Fujiwara, Y. ;
Lichinitser, M. ;
Tonkin, K. ;
Yardley, D. ;
Fan, M. ;
Jiang, Q. ;
Jun, S. ;
Dansey, R. ;
Braun, A. .
CANCER RESEARCH, 2009, 69 (24) :490S-490S
[15]   Zoledronic acid and atrial fibrillation in cancer patients with bone metastases [J].
Aksoy, S. ;
Dizdar, O. ;
Turgut, D. ;
Dede, D. Sener ;
Arslan, C. ;
Harputluoglu, H. ;
Altundag, K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[16]   Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases [J].
Chen, TL ;
Berenson, J ;
Vescio, R ;
Swift, R ;
Gilchick, A ;
Goodin, S ;
LoRusso, P ;
Ma, PM ;
Ravera, C ;
Deckert, F ;
Schran, H ;
Seaman, J ;
Skerjanec, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11) :1228-1236
[17]   Zoledronic acid in breast cancer patients with bone metastasis [J].
Halim, I. Abdel ;
El Ashry, M. ;
El Sherbini, E. ;
El Sadda, W. .
EJC SUPPLEMENTS, 2009, 7 (02) :279-280
[18]   Zoledronic acid and survival in breast cancer patients with bone Metastases and elevated markers of osteoclast activity [J].
Lipton, Allan ;
Cook, Richard J. ;
Major, Pierre ;
Smith, Matthew R. ;
Coleman, Robert E. .
ONCOLOGIST, 2007, 12 (09) :1035-1043
[19]   Long-term safety of zoledronic acid for the treatment of patients with breast cancer and bone metastases [J].
Lipton, A. ;
Dewar, R. ;
Conte, R. ;
Zheng, M. .
EJC SUPPLEMENTS, 2004, 2 (03) :142-142
[20]   Proven efficacy of zoledronic acid in the treatment of bone metastases in patients with breast cancer and other malignancies [J].
Cameron, D .
BREAST, 2003, 12 :S22-S29
12345